Get the Stockscreener App
93.84
0.14%
0.34
Overview
News
Price History
Option Chain
Financials
Why CVS Down?
Discussions
Forecast
Stock Split
Dividend History
Cvs Health Corp Stock (CVS) Forecast
The Cvs Health Corp (CVS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $84.17, representing a -10.30% decrease from the current price of $93.84. The highest analyst price target is $87.35, and the lowest is $80.99.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month CVS Price Target
Average 96.51
(+2.84% Upside)
Is Cvs Health Corp (CVS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.39 | Buy |
| STOCH(9,6) | 16.84 | Buy |
| STOCHRSI(14) | 10.35 | Buy |
| MACD(12,26) | -1.8972 | Sell |
| ADX(14) | 32.53 | Sell |
| William %R | -97.12 | Buy |
| CCI(14) | -139.75 | Sell |
Buy: 4
Sell: 3
Neutral: 0
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
100.56
Sell
|
99.36
Sell
|
| MA20 |
104.14
Sell
|
101.72
Sell
|
| MA50 |
101.97
Sell
|
100.30
Sell
|
| MA100 |
91.99
Buy
|
94.82
Sell
|
| MA200 |
85.17
Buy
|
87.14
Buy
|
Buy: 3
Sell: 7
Neutral: 0
Summary: Sell
According to our latest analysis, CVS could be considered a Strong Sell, with 17 technical analysis indicators signaling 7 Buy signals, 10 signaling Sell signals and 0 Neutral signals. This might not be a good time to consider opening new positions on CVS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.39 indicates that CVS is oversold. This indicates that CVS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 16.84 indicates that CVS is oversold. This indicates that CVS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 10.35 indicates that CVS is oversold. This suggests that CVS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.53 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -139.75 indicates that CVS is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term CVS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Cvs Health Corp financial reports and earnings history, Cvs Health Corp (CVS) stock could reach $58.15 by 2030, $82.14 by 2040 and $114.71 by 2050. See the projected annual prices until 2050 of the Cvs Health Corp stock below:
- Cvs Health Corp (CVS) is expected to reach an average price of $71.87 in 2035, with a high prediction of $73.79 and a low estimate of $66.86. This indicates an $-23.42% rise from the last recorded price of $93.84.
- Cvs Health Corp (CVS) stock is projected to chart a bullish course in 2040, with an average price target of $76.97, representing an $-17.98% surge from its current level. The forecast ranges from a conservative $75.60 to a sky-high $82.14.
- Our analysts predict Cvs Health Corp (CVS) to jump -0.77% by 2045, soaring from $92.00 to an average price of $93.12, potentially reaching $108.46. While $92.00 is the low estimate, the potential upside is significant.
- Cvs Health Corp (CVS) stock is expected to climb by 2050, reaching an average of $113.37, a $20.82% jump from its current level. However, a wide range of estimates exists, with high and low targets of $114.71 and $107.03, respectively, highlighting the market's uncertainty.
Cvs Health Corp Stock (CVS) Year by Year Forecast
Cvs Health Corp Stock (CVS) Price Forecast for 2026
The predicted value for Cvs Health Corp (CVS) in 2026 is set at an average of $74.61. Estimates vary from a peak of $91.82 to a trough of $57.40, indicating an -20.49% surge from the present price of $93.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2026 | $82.53 | $80.99 | $87.35 | -12.05% |
| October, 2026 | $82.46 | $80.55 | $85.49 | -12.13% |
| November, 2026 | $87.60 | $82.03 | $88.09 | -6.65% |
| December, 2026 | $86.03 | $84.57 | $89.00 | -8.32% |
Cvs Health Corp Stock (CVS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Cvs Health Corp (CVS) is $97.73, with a high forecast of $112.46 and a low forecast of $82.99. This indicates an +4.14% increase from the last price of $93.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $88.74 | $82.99 | $88.80 | -5.43% |
| February, 2027 | $94.37 | $87.80 | $97.78 | +0.57% |
| March, 2027 | $101.57 | $89.98 | $103.43 | +8.24% |
| April, 2027 | $107.43 | $99.85 | $108.47 | +14.49% |
| May, 2027 | $109.70 | $100.90 | $111.36 | +16.91% |
| June, 2027 | $106.40 | $99.67 | $112.46 | +13.39% |
| July, 2027 | $102.42 | $102.30 | $110.90 | +9.15% |
| August, 2027 | $102.90 | $99.88 | $108.95 | +9.65% |
| September, 2027 | $99.27 | $92.69 | $104.13 | +5.78% |
| October, 2027 | $89.88 | $89.64 | $99.38 | -4.22% |
| November, 2027 | $95.40 | $90.61 | $97.17 | +1.66% |
| December, 2027 | $107.61 | $92.21 | $108.09 | +14.67% |
Cvs Health Corp Stock (CVS) Price Forecast for 2028
In 2028, Cvs Health Corp (CVS) is projected to reach an average price of $88.02, with a high projection of $108.48 and a low estimate of $67.56. This indicates an -6.20% fall from the last price of $93.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $100.66 | $98.97 | $108.48 | +7.26% |
| February, 2028 | $96.59 | $96.49 | $104.81 | +2.93% |
| March, 2028 | $95.92 | $87.50 | $102.30 | +2.21% |
| April, 2028 | $102.48 | $94.74 | $103.99 | +9.21% |
| May, 2028 | $94.78 | $93.66 | $106.05 | +1.00% |
| June, 2028 | $88.22 | $87.97 | $94.97 | -5.99% |
| July, 2028 | $90.88 | $85.82 | $91.84 | -3.15% |
| August, 2028 | $78.32 | $77.88 | $91.79 | -16.54% |
| September, 2028 | $78.76 | $73.33 | $79.70 | -16.07% |
| October, 2028 | $71.90 | $69.32 | $78.52 | -23.38% |
| November, 2028 | $71.21 | $67.56 | $71.73 | -24.11% |
| December, 2028 | $70.35 | $67.86 | $74.05 | -25.03% |
Cvs Health Corp Stock (CVS) Price Forecast for 2029
The 2029 price forecast for Cvs Health Corp Stock (CVS) is $69.85 on average, with a high prediction of $84.47 and a low estimate of $55.23. This represents an -25.56% decrease from the previous price of $93.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $75.91 | $69.92 | $77.44 | -19.10% |
| February, 2029 | $68.54 | $65.84 | $78.60 | -26.96% |
| March, 2029 | $72.09 | $66.27 | $72.70 | -23.17% |
| April, 2029 | $72.76 | $69.31 | $74.07 | -22.46% |
| May, 2029 | $68.90 | $65.63 | $74.56 | -26.57% |
| June, 2029 | $69.70 | $67.93 | $70.91 | -25.72% |
| July, 2029 | $80.18 | $68.99 | $80.61 | -14.55% |
| August, 2029 | $75.59 | $71.42 | $84.47 | -19.44% |
| September, 2029 | $78.42 | $72.81 | $79.52 | -16.43% |
| October, 2029 | $79.71 | $74.27 | $80.73 | -15.06% |
| November, 2029 | $70.98 | $69.19 | $81.98 | -24.37% |
| December, 2029 | $57.51 | $55.23 | $71.44 | -38.71% |
Cvs Health Corp Stock (CVS) Price Forecast for 2030
Cvs Health Corp Stock (CVS) is expected to reach an average price of $66.65 in 2030, with a high forecast of $79.19 and a low forecast of $54.12. This signifies an -28.97% decrease from the last price of $93.84.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $56.74 | $54.12 | $58.15 | -39.53% |
| February, 2030 | $59.91 | $55.16 | $62.53 | -36.16% |
| March, 2030 | $58.08 | $57.41 | $60.88 | -38.10% |
| April, 2030 | $63.25 | $55.40 | $64.98 | -32.60% |
| May, 2030 | $65.51 | $62.09 | $67.65 | -30.19% |
| June, 2030 | $67.52 | $62.54 | $69.32 | -28.04% |
| July, 2030 | $77.85 | $67.35 | $78.11 | -17.04% |
| August, 2030 | $76.93 | $75.05 | $79.19 | -18.02% |
| September, 2030 | $74.29 | $74.01 | $77.33 | -20.84% |
| October, 2030 | $73.56 | $69.43 | $78.85 | -21.61% |
| November, 2030 | $60.16 | $55.91 | $74.96 | -35.89% |
| December, 2030 | $57.73 | $54.45 | $62.81 | -38.48% |
0.71%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):